Topic: prescription drug sales

Roche will wrest the pharma-sales crown from Novartis by 2022

Crosstown rivals Novartis and Roche will tussle for the No. 1 spot in world prescription drugs sales by 2022, with Roche barely coming out ahead at the finish line, according to a new market analysis. That’ll happen as the industry rides a 6.3% annual growth rate, passing the $1 trillion mark along the way.